Related Experiment Video
Updated: Aug 17, 2026
Electrophoretic Mobility Shift Assay (EMSA) for the Study of RNA-Protein Interactions: The IRE/IRP Example
Published on: December 3, 2014
Altered body iron distribution and microcytosis in mice deficient in iron regulatory protein 2 (IRP2)
Bruno Galy1, Dunja Ferring, Belen Minana
1European Molecular Biology Laboratory, Heidelberg, Germany.
Abstract:
Iron regulatory protein 2 (IRP2)-deficient mice have been reported to suffer from late-onset neurodegeneration by an unknown mechanism. We report that young adult Irp2-/- mice display signs of iron mismanagement within the central iron recycling pathway in the mammalian body, the liver-bone marrow-spleen axis, with altered body iron distribution and compromised hematopoiesis. In comparison with wild-type littermates, Irp2-/- mice are mildly microcytic with reduced serum hemoglobin levels and hematocrit. Serum iron and transferrin saturation are unchanged, and hence microcytosis is not due to an overt decrease in systemic iron availability. The liver and duodenum are iron loaded, while the spleen is iron deficient, associated with a reduced expression of the iron exporter ferroportin. A reduction in transferrin receptor 1 (TfR1) mRNA levels in the bone marrow of Irp2-/- mice can plausibly explain the microcytosis by an intrinsic defect in erythropoiesis due to a failure to adequately protect TfR1 mRNA against degradation. This study links a classic regulator of cellular iron metabolism to systemic iron homeostasis and erythropoietic TfR1 expression. Furthermore, this work uncovers aspects of mammalian iron metabolism that can or cannot be compensated for by the expression of IRP1.
Insights
Iron regulatory protein 2 (IRP2) deficiency disrupts systemic iron balance, causing microcytic anemia in mice. This study reveals IRP2’s crucial role in iron homeostasis and red blood cell production.
Area of Science:
- Biochemistry
- Hematology
- Physiology
Background:
- Iron regulatory protein 2 (IRP2) deficiency is linked to neurodegeneration, but the underlying mechanisms are unclear.
- IRP2 is a key regulator of cellular iron metabolism.
Purpose of the Study:
- To investigate the role of IRP2 in systemic iron homeostasis and hematopoiesis.
- To elucidate the mechanism behind IRP2 deficiency-induced microcytic anemia.
Main Methods:
- Analysis of iron distribution in liver, bone marrow, and spleen of IRP2-deficient mice.
- Assessment of hematological parameters, including red blood cell indices and serum iron.
- Quantification of ferroportin and transferrin receptor 1 (TfR1) mRNA levels.
Main Results:
- IRP2-deficient mice exhibit altered iron distribution, with iron loading in the liver/duodenum and deficiency in the spleen.
- Mild microcytic anemia with reduced hemoglobin and hematocrit was observed, independent of systemic iron availability.
- Reduced TfR1 mRNA in bone marrow suggests impaired erythropoiesis due to compromised TfR1 mRNA stability.
Conclusions:
- IRP2 is essential for maintaining systemic iron homeostasis and proper erythropoiesis.
- IRP2 deficiency leads to microcytic anemia through impaired TfR1 regulation in erythroid precursors.
- This study highlights IRP2's role in the liver-bone marrow-spleen iron axis and uncovers compensatory roles of IRP1.
